Associated Papers
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.
Zhou Y et al.
Science Advances, 2021
34516913 (PubMed )
Supplement: sciadv.abi6856_tables_s1_to_s8.zip › sciadv.abi6856_Table_S4.xlsx › Sheet1
Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha - 863 C/A Single Nucleotide Polymorphism in the Susceptibility to Systemic Lupus Erythematosus.
Katkam SK et al.
Indian Journal of Clinical Biochemistry : Ijcb, 2021
Systematic Review by Multivariate Meta-analyses on the Possible Role of Tumor Necrosis Factor-α Gene Polymorphisms in Association with Ischemic Stroke.
Niu YM et al.
Neuromolecular Medicine, 2015
Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
Hossain MA et al.
Gene, 2014
Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk.
Liang Y et al.
International Journal of Rheumatic Diseases, 2013
The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.
Ma B et al.
Human Immunology, 2013
Polymorphisms of tumor necrosis factor-α promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population.
Chung WT et al.
Rheumatology International, 2011
The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behçet's disease.
Chang HK et al.
Scandinavian Journal of Rheumatology, 0
Select a paper to view details